SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Muses rapid early adoption and Meta Connects AI-agent and smart-glasses announcements are driving attention, with bulls seeing a new consumer-AI growth opportunity and skeptics questioning monetization, privacy, and whether the products justify the recent rally. The stocks sharp run has also fueled debate over a potential sell-the-news pullback.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

GOOGLs sharp selloff has traders pointing to hot economic data and rising Treasury yields, which revived expectations for further Fed rate hikes and pressured growth stocks; some also worry Metas Muse could intensify competition in AI and search. Others view the decline as an overreaction and a buying opportunity.

McDonald's Corp. engages in the operation and franchising of restaurants. The firm operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. Its products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, and McCafe beverages. The company was founded by Raymond Albert Kroc on April 15, 1955 and is headquartered in Chicago, IL.

McDonald`s Corp

McDonald's Corp

McDonalds shares sold off after its investor-day outlook emphasized persistent inflation and sluggish restaurant traffic, alongside substantial spending on restaurant upgrades and franchisee support. Traders debate whether the growth plan can address affordability and weaker customer demand, while some see the steep decline and oversold conditions as a buying opportunity.

Alphabet Inc - Ordinary Shares - Class C

GOOGs selloff is fueling concern that Metas Muse and other AI rivals may be outpacing Google, with traders questioning Geminis competitive position; speculation about Gemini 4 and dip-buying offers a counterpoint. Some also blame rising Treasury yields and rate-hike fears for pressure on the stock and broader tech market.

Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.

Unity Software Inc

Traders are linking Unitys rally to Meta Connect, where Unitys role as a supported engine for Metas VR platforms has raised expectations for a possible Unity-related announcement. Heavy call-option activity has fueled short-squeeze speculation, though some traders note that no specific Unity news has been confirmed and the move may be driven by positioning.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Vikings positive VK2735 weight-loss maintenance data has been followed by a proposed stock-and-convertible-notes offering, fueling volatile trading. Traders are divided over near-term dilution and lost momentum versus the added funding for development and potential commercialization; buyout or partnership talk remains speculative.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Rising Treasury yields and stronger business-activity data have intensified concern that the Fed may raise rates again, weighing on SPY. Traders are split between expecting more downside and treating the pullback as buyable, arguing the market has remained resilient despite higher yields.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLASs discussion centers on the pending 80th-event trigger and final analysis of its Phase 3 REGAL trial of GPS in AML. Bulls view the prolonged event interval as a possible sign of longer survival, while skeptics note that the blinded data cannot show which treatment arm is responsible; buyout talk and anticipated SLS009 data are also being debated but remain speculative.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerrys first Alloy Kore design win, selected by Coreturathe Daimler Truck and Volvo Group venturehas focused attention on QNXs growth potential ahead of earnings. Bulls see the deal and NVIDIAs QNX references as validation of the software story, while skeptics question how quickly backlog will translate into revenue and look to earnings and guidance for proof of execution.

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Fastlys rally is drawing attention to its investor-day strategy and new AI-focused products for edge computing and security, alongside growing interest in agentic-AI traffic. Traders are debating whether the AI narrative and reported Meta Muse traffic could support a lasting re-rating, while some caution that the revenue impact is unproven and the sharp move may fade.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers

Tempest Therapeutics (NASDAQ:TPST) stock increased by 41.6% to $1.07 during Tuesday's after-market session. The company's market cap stands at $12.9 million.
Jupiter Neurosciences (NASDAQ:JUNS) stockread more...

12 Health Care Stocks Moving In Friday's Intraday Session

Gainers

Werewolf Therapeutics (NASDAQ:HOWL) shares increased by 108.1% to $0.9 during Friday's regular session. The market value of their outstanding shares is at $20.9 million.
Jupiter Neurosciences (NASDAQ:JUNS)read more...

Jupiter Neurosciences Stock Surges Friday: What's Driving the Action?

Shares of Jupiter Neurosciences are surging Friday morning after partner PharmAla Biotech announced a series of corporate updates.read more...

12 Health Care Stocks Moving In Friday's Pre-Market Session

Gainers

Werewolf Therapeutics (NASDAQ:HOWL) shares moved upwards by 74.6% to $0.75 during Friday's pre-market session. The company's market cap stands at $20.9 million.
Jupiter Neurosciences (NASDAQ:JUNS)read more...

AI, Biotech and Billion-Dollar Deals Ignite Market Momentum as Breakout Companies Make Big Moves

A fresh round of corporate announcements is highlighting several of Wall Street's strongest investment themes. $JUNS, $KBLB, $KIDZ, $HIHO, $VIVK, $UTZ

Jupiter Neurosciences Lands Potential $100 Million Psychedelic Drug Deal as PharmAla Licenses ALA-002

Momentum continues to build across the emerging psychedelic medicine sector as PharmAla Biotech (OTCQB:MDXXF) announced a definitive licensing agreement granting Jupiter Neurosciences (NASDAQ:JUNS) exclusive rights to develop, manufacture, and commercialize ALA-002 in the United States. The agreement, valued at up to approximately US$100 million in potential consideration, reflects the growing interest in next-generation neuropsychiatric therapies and strategic partnerships designed to advance promising clinical assets while managing development risk.

Micro-Cap Biotech Stocks Surge After Breakthrough Psychedelics Licensing Announcement

The psychedelics market continues to expand rapidly as researchers gain a deeper understanding of its potential therapeutic benefits. Today, a leader in the sector announced a partnership with another micro-cap biotech company to further advance its development efforts in the space. Investors responded positively to the news, sending shares of both companies sharply higher following the announcement.PharmAla Biotech Holdings Inc. (CSE: MDMA) (OTCQB: MDXXF) announced that it has signed a term sheet with Jupiter Neurosciences, Inc. (NASDAQ: JUNS) to grant the company exclusive perpetual U.S. ...

Jupiter Stock Soars After $100 Million ALA-002 Licensing Deal

Jupiter Neurosciences shares are rising Wednesday after it announced the acquisition of US licensing rights to ALA-002 from Pharmala Biotech.read more...

JUNS Stock Sees Best Single-Day Gains In Almost A Year On $100M MDMA Drug Licensing Deal  – Retail Expects Shares To Hit $1

Equity

Jupiter Neurosciences signed a term sheet to acquire exclusive U.S. licensing rights to an MDMA-based drug candidate developed by PharmAla Biotech.

Jupiter Neurosciences, Inc. is a clinical-stage pharmaceutical company engaged in treating neuroinflammation with a current focus on CNS disorders and rare diseases. The firm offers JOTROL, an enhanced orally administered resveratrol formulation, designed to deliver therapeutically relevant, safe levels of resveratrol. The company was founded by Christer Rosén, Alexander Rosén, Claes Wahlestedt, Marshall Hayward, and Shaun P. Brothers in January 2016 and is headquartered in Jupiter, FL.

Jupiter Neurosciences Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

JUNS Jupiter Neurosciences Inc.

Fundamentals

Latest JUNS News